NovoCure (NVCR) Total Non-Current Liabilities (2014 - 2026)
NovoCure recorded quarterly Total Non-Current Liabilities of $239.6 million in Q1 2026, little changed quarter-over-quarter from $240.6 million in Q4 2025, and up 66.94% year-over-year from $143.5 million in Q1 2025.
NovoCure's Total Non-Current Liabilities history runs 13 years deep, the most recent figure standing at $239.6 million for Q1 2026.
- In Q1 2026, Total Non-Current Liabilities rose 66.94% year-over-year to $239.6 million; the TTM figure through Mar 2026 stood at $239.6 million (up 66.94% YoY), while the FY2025 annual figure was $240.6 million, up 93.73% from the prior year.
- Total Non-Current Liabilities came in at $239.6 million for Q1 2026 at NovoCure, roughly flat from $240.6 million in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $681.2 million in Q2 2024 to a low of $124.2 million in Q4 2024.
- A 5-year average of $428.6 million and a median of $586.5 million in 2022 frame the typical range for Total Non-Current Liabilities.
- Across the five-year window, Total Non-Current Liabilities tumbled 79.45% in 2024 and soared 93.73% in 2025, its largest moves.
- NovoCure's Total Non-Current Liabilities stood at $591.7 million in 2022, then gained by 2.17% to $604.5 million in 2023, then sank by 79.45% to $124.2 million in 2024, then soared by 93.73% to $240.6 million in 2025, then slipped by 0.42% to $239.6 million in 2026.
- According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $239.6 million, $240.6 million, and $243.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 20.94 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 40.52 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 15.78 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 2.44 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 9.85 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 3.53 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 24.21 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 3.47 Bn |
| 10 | NovoCure | 1.90 Bn | 1.47 Bn | 135.13 Mn | 239.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 239.63 Mn |
| Dec 31, 2025 | 240.63 Mn |
| Sep 30, 2025 | 243.86 Mn |
| Jun 30, 2025 | 146.80 Mn |
| Mar 31, 2025 | 143.55 Mn |
| Dec 31, 2024 | 124.21 Mn |
| Sep 30, 2024 | 126.20 Mn |
| Jun 30, 2024 | 681.24 Mn |
| Mar 31, 2024 | 601.84 Mn |
| Dec 31, 2023 | 604.52 Mn |
| Sep 30, 2023 | 595.49 Mn |
| Jun 30, 2023 | 593.25 Mn |
| Mar 31, 2023 | 593.42 Mn |
| Dec 31, 2022 | 591.70 Mn |
| Sep 30, 2022 | 587.74 Mn |
| Jun 30, 2022 | 585.60 Mn |
| Mar 31, 2022 | 586.53 Mn |
| Dec 31, 2021 | 586.40 Mn |
| Sep 30, 2021 | 582.74 Mn |
| Jun 30, 2021 | 583.58 Mn |
| Mar 31, 2021 | 585.01 Mn |
| Dec 31, 2020 | 461.85 Mn |
| Sep 30, 2020 | 28.68 Mn |
| Jun 30, 2020 | 176.00 Mn |
| Mar 31, 2020 | 176.30 Mn |
| Dec 31, 2019 | 175.35 Mn |
| Sep 30, 2019 | 173.09 Mn |
| Jun 30, 2019 | 173.72 Mn |
| Mar 31, 2019 | 172.91 Mn |
| Dec 31, 2018 | 162.97 Mn |
| Sep 30, 2018 | 152.49 Mn |
| Jun 30, 2018 | 152.55 Mn |
| Mar 31, 2018 | 152.60 Mn |
| Dec 31, 2017 | 101.53 Mn |
| Sep 30, 2017 | 104.61 Mn |
| Jun 30, 2017 | 104.33 Mn |
| Mar 31, 2017 | 103.81 Mn |
| Dec 31, 2016 | 102.85 Mn |
| Sep 30, 2016 | 103.14 Mn |
| Jun 30, 2016 | 29.26 Mn |
| Mar 31, 2016 | 29.16 Mn |
| Dec 31, 2015 | 27.89 Mn |
| Sep 30, 2015 | 26.64 Mn |
| Dec 31, 2014 | 2.33 Mn |